CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.

BMC Cancer · 2021 · PMC8465776 · PMID 34563169

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

HGF expression may be correlated with cancer cell metastasis and infiltration but the latter did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

In CABOSUN and in METEOR trials evaluating Cabozantinib in metastatic renal cell carcinoma, MET surexpression assessed by immunochemistry showed a trend toward more benefit in MET-positive tumors but it was not statistically significant, even with combined data of both trials [ 19 – 21 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.